Quince Therapeutics relaunches as IRulya Therapeutics

The company said it changed its name to IRulya Therapeutics effective Oct. 9 and will trade on Nasdaq under ticker IRLA from Oct. 12. It also announced new leadership appointments and said its cash balance should fund operations through the end of 2028.